Cargando…
Mild cognitive impairment and its management in older people
Mild cognitive impairment (MCI) is a common condition in the elderly. It is characterized by deterioration of memory, attention, and cognitive function that is beyond what is expected based on age and educational level. MCI does not interfere significantly with individuals’ daily activities. It can...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401355/ https://www.ncbi.nlm.nih.gov/pubmed/25914527 http://dx.doi.org/10.2147/CIA.S73922 |
_version_ | 1782367137512292352 |
---|---|
author | Eshkoor, Sima Ataollahi Hamid, Tengku Aizan Mun, Chan Yoke Ng, Chee Kyun |
author_facet | Eshkoor, Sima Ataollahi Hamid, Tengku Aizan Mun, Chan Yoke Ng, Chee Kyun |
author_sort | Eshkoor, Sima Ataollahi |
collection | PubMed |
description | Mild cognitive impairment (MCI) is a common condition in the elderly. It is characterized by deterioration of memory, attention, and cognitive function that is beyond what is expected based on age and educational level. MCI does not interfere significantly with individuals’ daily activities. It can act as a transitional level of evolving dementia with a range of conversion of 10%–15% per year. Thus, it is crucial to protect older people against MCI and developing dementia. The preventive interventions and appropriate treatments should improve cognitive performance, and retard or prevent progressive deficits. The avoidance of toxins, reduction of stress, prevention of somatic diseases, implementation of mental and physical exercises, as well as the use of dietary compounds like antioxidants and supplements can be protective against MCI. The modification of risk factors such as stopping smoking, as well as the treatment of deficiency in vitamins and hormones by correcting behaviors and lifestyle, can prevent cognitive decline in the elderly. The progressive increase in the growth rate of the elderly population can enhance the rate of MCI all over the world. There is no exact cure for MCI and dementia; therefore, further studies are needed in the future to determine causes of MCI and risk factors of progression from MCI to dementia. This will help to find better ways for prevention and treatment of cognitive impairment worldwide. |
format | Online Article Text |
id | pubmed-4401355 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-44013552015-04-24 Mild cognitive impairment and its management in older people Eshkoor, Sima Ataollahi Hamid, Tengku Aizan Mun, Chan Yoke Ng, Chee Kyun Clin Interv Aging Review Mild cognitive impairment (MCI) is a common condition in the elderly. It is characterized by deterioration of memory, attention, and cognitive function that is beyond what is expected based on age and educational level. MCI does not interfere significantly with individuals’ daily activities. It can act as a transitional level of evolving dementia with a range of conversion of 10%–15% per year. Thus, it is crucial to protect older people against MCI and developing dementia. The preventive interventions and appropriate treatments should improve cognitive performance, and retard or prevent progressive deficits. The avoidance of toxins, reduction of stress, prevention of somatic diseases, implementation of mental and physical exercises, as well as the use of dietary compounds like antioxidants and supplements can be protective against MCI. The modification of risk factors such as stopping smoking, as well as the treatment of deficiency in vitamins and hormones by correcting behaviors and lifestyle, can prevent cognitive decline in the elderly. The progressive increase in the growth rate of the elderly population can enhance the rate of MCI all over the world. There is no exact cure for MCI and dementia; therefore, further studies are needed in the future to determine causes of MCI and risk factors of progression from MCI to dementia. This will help to find better ways for prevention and treatment of cognitive impairment worldwide. Dove Medical Press 2015-04-10 /pmc/articles/PMC4401355/ /pubmed/25914527 http://dx.doi.org/10.2147/CIA.S73922 Text en © 2015 Eshkoor et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Eshkoor, Sima Ataollahi Hamid, Tengku Aizan Mun, Chan Yoke Ng, Chee Kyun Mild cognitive impairment and its management in older people |
title | Mild cognitive impairment and its management in older people |
title_full | Mild cognitive impairment and its management in older people |
title_fullStr | Mild cognitive impairment and its management in older people |
title_full_unstemmed | Mild cognitive impairment and its management in older people |
title_short | Mild cognitive impairment and its management in older people |
title_sort | mild cognitive impairment and its management in older people |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401355/ https://www.ncbi.nlm.nih.gov/pubmed/25914527 http://dx.doi.org/10.2147/CIA.S73922 |
work_keys_str_mv | AT eshkoorsimaataollahi mildcognitiveimpairmentanditsmanagementinolderpeople AT hamidtengkuaizan mildcognitiveimpairmentanditsmanagementinolderpeople AT munchanyoke mildcognitiveimpairmentanditsmanagementinolderpeople AT ngcheekyun mildcognitiveimpairmentanditsmanagementinolderpeople |